203 Therefore, reviews or intervention strategies discussing SIRT1 in MASLD must avoid the oversimplified assumption that SIRT1 activation is always beneficial and instead adopt a refined, stage- and cell-specific framework
This finding is consistent with other reports that these genes expression typically peaks during early progenitor stage and decreases towards the final hepatocyte-like cells stage 24,25,26
Gastrointestinal side effects
Lowering glucagon (a hormone that raises blood sugar)
Cells, therefore, employ antioxidantsthe most abundant of which in the brain is glutathione (GSH)to neutralize ROS by serving as electron donors to limit cell damage(Dringen, 2000
This could pose health risks, and invasive treatments would be required to remove the accumulated materials, making the overall risk greater than the benefit and undermining the purpose of developing MNMs